Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
88,879,779
-
Share change
-
-1,465,848
-
Total reported value
-
$7,563,734,979
-
Put/Call ratio
-
117%
-
Price per share
-
$85.17
-
Number of holders
-
383
-
Value change
-
-$135,795,395
-
Number of buys
-
185
-
Number of sells
-
192
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q4 2021
As of 31 Dec 2021 NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) had 383 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 88,879,779 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Bellevue Group AG, JPMORGAN CHASE & CO, Bank of New York Mellon Corp, EATON VANCE MANAGEMENT, and GOLDMAN SACHS GROUP INC.
This table shows 387 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.